PPARG and fatty liver disease: Overexpression of SHBG, by creating a double transgenic mouse (SHBG-C57BL/ksJ-db/db), in a NAFLD model or in a diet–induced model of hepatic steatosis, significantly reduced liver fat accumulation through PPARγ modulation (62).